Postprandial plasma lipoproteins in normal and hypertriglyceridaemic subjects and their in vitro effect on platelet activity: Differences between saturated and polyunsaturated fats

References

• Havel R J, Kane J P, Kashyap M L. Interchange of apolipoprotein between chylomicrons and high‐density lipoproteins during alimentary lipaemia in man. J Clin Invest 1973; 52: 32–8
   PubMed Web of Science ®Google Scholar
• Redgrave T G, Small D M. Quantitation of the transfer of surface phospholipids of chylomicrons to the high‐density lipoprotein fraction during the catabolism of chylomicrons in the rat. J Clin Invest 1979; 62: 162–9
   Google Scholar
• Zilversmit D B. Atherogenesis: a postprandial phenomenon. Circulation 1979; 60: 473–81
   PubMed Web of Science ®Google Scholar
• Nordoy A, Lagarde M, Renaud S. Platelets during alimentary hyperlipaemia induced by cream and cod liver oil. Eur J Clin Invest 1984; 14: 339–45
   PubMed Web of Science ®Google Scholar
• Sanders T AB. Dietary fat and platelet function. Clin Sci 1983; 65: 343–50
   Google Scholar
• Hornstra G. Dietary fats and arterial thrombosis. Haemostasis 1974; 2: 21–52
   Google Scholar
• Aviram M, Brook J G, Lees R S. Low‐density lipoprotein binding to human platelets: role of charge and of specific amino acids. Biochem Biophys Res Commun 1981; 99: 308–18
   PubMed Web of Science ®Google Scholar
• Aviram M, Brook J G. Platelet interaction with high‐ and low‐density lipoproteins. Atherosclerosis 1983; 46: 259–68
   PubMed Web of Science ®Google Scholar
• Smulevitch A, Brook J G, Aviram M. Interaction of modified low‐density lipoprotein with human platelets in normal and homozygous hyper‐ cholesterolaemic subjects. Biochem J 1984; 224: 13–20
   PubMedGoogle Scholar
• Aviram M, Deckelbaum R J, Brook J G. Platelet function in a case with abetalipoproteinaemia. Atherosclerosis 1985; 57: 313–23
   PubMed Web of Science ®Google Scholar
• Ziegenhorn J. An improved method for enzymatic determination of serum triglyceride. Clin Chem 1975; 21: 1627–30
   PubMed Web of Science ®Google Scholar
• Zak B. Cholesterol methodologies: a review. Clin Chem 1977; 23: 1201–4
   PubMed Web of Science ®Google Scholar
• Alaupovic D, Curry M, McConathy W J (1978) Quantitative determination of human plasma apolipoprotein by electroimmunoassay. International Conference on Atherosclerosis. 1978, L A Carlson. Raven Press, New York, 105–11
   Google Scholar
• Aviram M. Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinaemic patients. Biochem Med 1983; 30: 111–8
   PubMed Web of Science ®Google Scholar
• Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–75
   PubMed Web of Science ®Google Scholar
• Warnick G R, Mayfield C, Albers J J, Hazzard R W. Gel isoelectric focusing method for specific diagnosis of familial hyperlipoproteinaemia, type III. Clin Chem 1979; 25: 279–83
   PubMedGoogle Scholar
• Chin H P, Blankenhorn P H. Separation and quantitative analysis of serum lipoproteins by means of electrophoresis on cellulose acetate. Clin Chim Acta 1968; 20: 305–8
   PubMed Web of Science ®Google Scholar
• Born G RV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1969; 194: 927–30
   Google Scholar
• Jerushalmy Z, Zucker M B. Some effects of fibrinogen degradation products (FDP) on blood platelets. Thromb Diath Haemorrh 1966; 15: 413–8
   PubMedGoogle Scholar
• Viener A, Brook J G, Aviram M. Abnormal plasma lipoprotein composition in hypercholesterolaemic patients induces platelet activation. Eur J Clin Invest 1984; 14: 207–13
   PubMed Web of Science ®Google Scholar
• Lewis B, Chait A, February A W, Mattock M. Functional overlap between chylomicrons and very‐low‐density lipoproteins of human plasma during alimentary lipaemia. Atherosclerosis 1973; 17: 455–62
   PubMedGoogle Scholar
• Koga S, Yamanaga Y, Fugii S, Yamamoto K, Ibayashi H. Effects of oral and intravenous fat administration on the levels of apoproteins A‐I, A‐II and C‐III in human subjects. Atherosclerosis 1982; 41: 115–21
   PubMedGoogle Scholar
• Carlson L A, Ballantyne D. Changing relative proportions of apolipoproteins C‐II and C‐III of very‐low‐density lipoproteins in hypertriglyceridaemia. Atherosclerosis 1976; 23: 563–8
   PubMedGoogle Scholar
• Redgrave T G. Formation of cholesterol ester‐rich particulate lipids during metabolism of chylomicrons. J Clin Invest 1970; 49: 465–72
   PubMedGoogle Scholar
• Aviram M, Brook J G. The effect of blood constituents on platelet function: role of blood cells and plasma lipoproteins. Artery 1983; 11: 297–305
   PubMedGoogle Scholar
• Aviram M, Brook J G. Characterization of the effect of plasma lipoproteins on platelet function in vitro. Haemostasis 1983; 13: 344–50
   PubMedGoogle Scholar
• Koller E, Roller F, Doleschel W. Specific binding sites on human platelets for plasma lipoproteins. Z Physiol Chem 1982; 363: 395–405
   PubMedGoogle Scholar
• Aviram M, Fuhrman B, Brook J G. Chylomicrons from patients with type V hyperlipoproteinaemia inhibit platelet function. Atherosclerosis 1985; 56: 157–67
   PubMed Web of Science ®Google Scholar
• Aviram M, Sechter Y, Brook J G. Chylomicron‐like particles in severe hypertriglyceridaemia. Lipids 1985; 20: 211–5
   PubMed Web of Science ®Google Scholar
• Kenagy R D, Floren C H, Bierman E L, Kudchod‐kar B, Albers J J. Cholesterol homeostasis of skin fibroblasts after incubation with postabsorptive and postprandial lipoproteins: the effect of a fatty meal. Atherosclerosis 1982; 2: 290–5
   Google Scholar
• Aviram M, Sirtori C R, Collis S, Maderna P, Morazzoni G, Tremoli G. Plasma lipoproteins affect platelet malondialydehyde and thromboxane B2 production. Biochem Med 1985; 34: 29–36
   PubMed Web of Science ®Google Scholar
• Aviram M, Brook J G. Selective release from platelet granules induced by plasma lipoproteins. Biochem Med 1984; 32: 30–6
   PubMed Web of Science ®Google Scholar
• Aviram M, Brook J G. The effect of human plasma on platelet function in familial hyper‐cholesterolaemia. Thromb Res 1982; 26: 101–9
   PubMed Web of Science ®Google Scholar
• Brook J G, Winterstein G, Aviram M. Platelet function and lipoprotein levels after plasma exchange in patients with familial hypercholesterolaemia. Clin Sci 1983; 64: 637–42
   Google Scholar
• Aviram M, Brook J G, Tatarsky I, Levy Y, Carter A. Increased low‐density lipoprotein levels after splenectomy: a role for the spleen in cholesterol metabolism in myeloproliferative disorders. Am J Med Sci 1986; 291: 25–8
   PubMed Web of Science ®Google Scholar
• Aviram M, Carter A, Tatarsky I, Levy Y, Brook J G. Increased platelet aggregation following splenectomy in patients with myeloproliferative disease. Isr J Med Sci 1985; 21: 415–7
   PubMedGoogle Scholar
• Patch J R, Karlin J B, Scott Z W, Smith L C, Gotto A M. Inverse relationship between blood levels of high‐density lipoprotein subfraction 2 and magnitude of postprandial lipaemia. Proc Natl Acad Sci USA 1983; 80: 1449–53
   PubMedGoogle Scholar
• Baggio G, Fellini R, Baiocchi M R, Martini S, Baldo G, Manzato E, Crepaldi G. Relationship between triglyceride‐rich lipoprotein (chylomicrons and VLDL) and HDL2 and HDL, in the postprandial phase in humans. Atherosclerosis 1980; 37: 271–6
   PubMed Web of Science ®Google Scholar
• Groot P HE, Scheek L M. Effects of fat ingestion on high‐density lipoprotein profiles in human sera. J Lipid Res 1984; 25: 684–92
   PubMedGoogle Scholar